Evidence map›Paper›PMID 25817299›Full record

ArticleBMJ (Clinical research ed.)2015

Use of perioperative hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasty and association with adverse outcomes: a retrospective population based analysis.

Mathias Opperer, Jashvant Poeran, Rehana Rasul, Madhu Mazumdar, Stavros G Memtsoudis

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in BMJ (Clinical research ed.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. New Advances in the Treatment of Acute Pancreatitis.Current treatment options in gastroenterology · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Mathias OppererDepartment of Anesthesiology, Hospital for Special Surgery, New York, NY 10021, USA; Department of Anesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University, 5020 Salzburg, Austria.
Jashvant PoeranInstitute for Healthcare Delivery Science, Department of Population Health Science and Policy; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Rehana RasulInstitute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York.
Madhu MazumdarInstitute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York.
Stavros G MemtsoudisWeill Cornell Medical College, Department of Healthcare Policy and Research, New York; Department of Anesthesiology, Hospital for Special Surgery, New York; Department of Anesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University, Salzburg memtsoudiss@hss.edu.
Icahn School of Medicine at Mount Sinai · USHospital for Special Surgery · USParacelsus Medical University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine whether the perioperative use of hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasties are associated with an increased risk for perioperative complications.

designRetrospective cohort study of population based data between 2006 and 2013.

settingData from 510 different hospitals across the United States participating in the Premier Perspective database.

participants1,051,441 patients undergoing elective total hip and knee arthroplasties. EXPOSURES: Perioperative fluid resuscitation with hydroxyethyl starch 6% or albumin 5%, or neither.

main outcome measuresAcute renal failure and thromboembolic, cardiac, and pulmonary complications.

resultsCompared with patients who received neither colloid, perioperative fluid resuscitation with hydroxyethyl starch 6% or albumin 5% was associated with an increased risk of acute renal failure (odds ratios 1.23 (95% confidence interval 1.13 to 1.34) and 1.56 (1.36 to 1.78), respectively) and most other complications. A recent decrease in hydroxyethyl starch 6% use was noted, whereas that of albumin 5% increased.

conclusionsSimilar to studies in critically ill patients, we showed that use of hydroxyethyl starch 6% was associated with an increased risk of acute renal failure and other complications in the elective perioperative orthopedic setting. This increased risk also applied to albumin 5%. These findings raise questions regarding the widespread use of these colloids in elective joint arthroplasty procedures.

Indexed as

Acute Kidney InjuryAgedAlbuminsArthroplasty, Replacement, HipArthroplasty, Replacement, KneeElective Surgical ProceduresFemaleHumansHydroxyethyl Starch DerivativesMaleMiddle AgedPerioperative CarePlasma SubstitutesPostoperative ComplicationsRetrospective StudiesTreatment OutcomeAlbuminsHydroxyethyl Starch DerivativesPlasma Substitutes

Identifiers

PMID25817299
PMCPMC4376265
OpenAlexW2096880753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.